ETERNA THERAPEUTICS INC

ERNA10 Dec 2024
Healthcare
$0.38
-0.16 (-16.23%)
Lowest Today
$0.33
Highest Today
$0.39
Today’s Open
$0.38
Prev. Close
$0.4
52 Week High
$2.63
52 Week Low
$0.27
To Invest in ETERNA THERAPEUTICS INC

ETERNA THERAPEUTICS INC

Healthcare
ERNA10 Dec 2024
-0.16 (-16.23%)
1M
3M
6M
1Y
5Y
Low
$0.33
Day’s Range
High
$0.39
0.33
52 Week Low
$0.27
52-Week Range
52 Week High
$2.63
0.27
1 Day
-
1 Week
+0.11%
1 month return
-68.1%
3 month return
-76.74%
6 month return
-80.51%
1 Year return
-77.04%
3 Years return
-99.66%
5 Years return
-99.63%
10 Years return
-
Institutional Holdings
CI Private Wealth LLC
0.51
Cypress Point Wealth Management, LLC
0.18
UBS Group AG
0.16
Naviter Wealth, LLC
0.15
Sippican Capital Adivsors
0.13
TWO SIGMA SECURITIES, LLC
0.06
Vanguard Group Inc
0.05
Fundamentals
Market Cap
20.54 mln
PB Ratio
2.1
PE Ratio
0
Enterprise Value
49.83 mln
Total Assets
49.13 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Organisation
ETERNA THERAPEUTICS INC
Employees
8
Industry
Biotechnology
CEO
Mr. Sanjeev  Luther
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step